Results 81 to 90 of about 17,658 (183)

Durability and Efficacy of Faricimab in Treatment-Resistant Retinal Edema Utilizing “Real-World” Dosing Regimens

Journal of Ophthalmology
Conclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant, James T. Kwan, Fina Barouch, Jeffrey Chang, David J. Ramsey, Jeffrey Marx, Gregory Blaha, Kendra Klein-Mascia   +7 more
doaj   +1 more source

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK

Clinical Ophthalmology, 2008
Sobha Sivaprasad, Nachiketa Acharya, Phil HykinMoorfields Eye Hospital, London, UKAbstract: The pathogenesis of age-related macular degeneration (AMD) is unclear, but it can take either a neovascular/exudative/wet form, characterized by choroidal ...
Sobha Sivaprasad, Nachiketa Acharya, Phil Hykin   +2 more
doaj  

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

Clinical Ophthalmology, 2014
Paul Hahn Duke Eye Center, Duke University Medical Center, Durham, NC, USA Abstract: Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy in vitrectomized eyes remains a challenge due to the reduced half-life of these agents ...
Hahn P
doaj  

Early SUSVIMO in Neovascular Age-Related Macular Degeneration: Real Word Case Report and Clinical Implications

International Medical Case Reports Journal
Jakob Pericak,1,2 Eric K Chin,3,4 David RP Almeida2 1State University of New York at Geneseo, Geneseo, NY, USA; 2Erie Retina Research & Center for Advanced Surgical Exploration, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA;
Pericak J, Chin EK, Almeida DRP
doaj  

Hypertrophic sub-retinal scar in neovascular age related macular degeneration

Indian Journal of Ophthalmology. Case Reports, 2021
Samendra Karkhur, Deepak Soni, Bhavana Sharma   +2 more
doaj   +1 more source

Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets

Neural Regeneration Research
Subretinal fibrosis is the end-stage sequelae of neovascular age-related macular degeneration. It causes local damage to photoreceptors, retinal pigment epithelium, and choroidal vessels, which leads to permanent central vision loss of patients with ...
Jingxiang Zhang, Xia Sheng, Quanju Ding, Yujun Wang, Jiwei Zhao, Jingfa Zhang   +5 more
doaj   +1 more source

Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

Pharmaceuticals
Our objective was to evaluate changes in patient-reported outcome measures using the NEI-VFQ 25 questionnaire during a treat and extend regimen in naive neovascular Age-Related Macular Degeneration patients, and its correlation with anatomical and ...
Pablo Almuiña-Varela, Laura García-Quintanilla, María José Rodríguez-Cid, María Gil-Martínez, Maximino J. Abraldes, Francisco Gómez-Ulla, Ana Estany-Gestal, Jorge Miguel Alcántara-Espinosa, Maribel Fernández-Rodríguez, Anxo Fernández-Ferreiro   +9 more
doaj   +1 more source

Real-world outcomes of faricimab in treatment-naïve patients with neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Chang W, Kim J, Jeon J, Park S.
europepmc   +1 more source

Durability of Three Monthly Loading Doses with Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration. [PDF]

Ophthalmol Ther
Turan L, Bjerager J, Subhi Y, Klefter ON, Hajari JN, Schneider M.   +5 more
europepmc   +1 more source

Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study. [PDF]

Ophthalmol Ther
Saraf A, Garima K, Dharwadkar S, Keshav S, Patwardhan SD, Giri NB, Saxena M, Phadke Y, Khare A, Mishra A, Kumar V, Singh S.   +11 more
europepmc   +1 more source